Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chronium-induced cytotoxicity or genotoxicity

Molecular and Cellular Biochemistry

Volumn 255, Issue 1-2, 2004, Pages 103-112

  Wise, Sandra S ^a   Elmore, Lynne W ^b   Holt, Shawn E ^b   Little, Jennifer E ^a   Antonucci, Peter G ^a   Bryant, Bronwyn H ^a   Wise Sr , John Pierce ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

Chromium; Chromosomal aberrations; Cytotoxicity; Genotoxicity; hTERT; Karyotype instability; Lead chromate; Lung cancer; Sodium chromate; Telomerase; WTHBF 6 cells

Indexed keywords

CARCINOGEN; CHROMIUM; CLASTOGEN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANCHORAGE INDEPENDENT GROWTH; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DIPLOIDY; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FIBROBLAST; FIBROSARCOMA; GENOTOXICITY; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; LUNG CARCINOGENESIS; LUNG CARCINOMA; REVIEW; TELOMERE;

EID: 0346969853     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000007266.82705.d9     Document Type: Review

References (45)

1. Agency for Toxic Substances and Disease Research: Top 20 hazardous substances: ATSDR/EPA priority list for 1997. U.S. Department of Health and Human Services Public Health Service/U.S. Environmental Protection Agency
2. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding, Vol. 49. International Agency for Research on Cancer, Lyons, France, 1990
3. National Occupational Exposure Survey, National Institute for Occupational Safety and Health, Cincinnati, Ohio, 1988
4. Johnson BL, DeRosa CT: The toxicological hazard of superfund hazardous waste sites. Rev Environ Health 12: 235-251, 1997
5. Damage and Threats caused by Hazardous Materials Sits, EPA/430-980/004, U.S. Environmental Protection Agency, Washington DC, 1980
6. Léonard A, Lauwerys RR: Carcinogenicity and mutagenicity of chromium. Mutat Res 76: 239-277, 1980
7. Levy LS, Vanitt S: Carcinogenicity and mutagenicity of chromium compounds: The association between bronchial metaplasia and neoplasia. Carcinogenesis 7: 831-835, 1986
8. Patierno SR, Banh D, Landolph JR: Transformation of C3H/10T1/2 mouse embryo cells by insoluble lead chromate but not soluble calcium chromate: Relationship to mutagenesis and internalization of lead chromate particles. Cancer Res 47: 3815-3823, 1988
9. Ishikawa Y, Nakagawa K, Satoh Y, Kitagawa T, Sugano H, Hirano T, Tsuchiya E: Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions: An autopsy study. Br J Cancer 70: 160-166, 1994
10. Ishikawa Y, Nakagawa K, Satoh Y, Kitagawa T, Sugano H, Hirano T, Tsuchiya E: 'Hot spots' of chromium accumulation at bifurcations of chromate workers' bronchi. Cancer Res 2342-2346, 1994
11. DeFlora S, Bagnasco M, Serra D, Zanacchi P: Genotoxicity of chromium compounds. A review. Mutat Res 238: 99-172, 1990
12. 4 in hamster and human cells. Mutat Res 278: 69-79, 1992
13. Wise JP, Orenstein JM, Patierno SR: Inhibition of lead chromate clastogenesis by ascorbate: Relationship to particle dissolution and uptake. Carcinogenesis 14: 429-434, 1993
14. Wise JP Sr, Stearns DM, Wetterhahn KE, Patierno SR: Cell-enhanced dissolution of carcinogenic lead chromate particles: The role of individual dissolution products in clastogenesis. Carcinogenesis 15: 2249-2254, 1994
15. Lechner JF, LaVeck MA: A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Cult Meth 9: 43-48, 1985
16. Wise JP Sr, Wise SS, Little JE: The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells. Mutat Res 517: 221-229, 2002
17. Singh J, Pritchard DE, Carlisle DL, McLean JA, Montaser A, Orenstein JM, Patierno SR: Internalization of carcinogenic lead chromate particles by cultured normal human lung epithelial cells. Formation of intracellular lead-inclusion bodies and induction of apoptosis. Toxicol Appl Pharm 161: 240-248, 1999
18. Fornace AJ Jr, Seres DS, Lechner JF, Harris CC: DNA-protein cross-linking by chromium salts. Chem Biol Interact. 36: 345-354, 1981
19. Xu J, Bubley GJ, Detrick B, Blankenship LJ, Patierno SR: Chromium(VI) treatment of normal human lung cells results in guanine-specific DNA polymerase arrest, DNA-DNA cross-links and S-phase blockade of cell cycle. Carcinogenesis 17: 1511-1517, 1996
20. Carlisle DL, Pritchard DE, Singh J, Owens BM, Blankenship LJ, Orenstein JM, Patierno SR: Apoptosis and p53 induction in human lung fibroblasts exposed to chromium(VI): Effect ofascorbate and tocopherol. Toxicol Sci 55: 60-68, 2000
21. Carlisle DL, Pritchard DE, Singh J, Patierno SR: Chromium(VI) induces p53-dependent apoptosis in diploid human lung and mouse dermal fibroblasts. Mol Carcinogen 28: 111-118, 2000
22. Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JR, Su RT, Brash DE, Park JB, Rhim JS, Harris CC: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 48: 1904-1909, 1988
23. Willey JC, Broussoud A, Sleemi A, Bennett WP, Cerutti P, Harris CC: Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res 51: 5370-5377, 1991
24. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chin C-P, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 207: 349-352, 1998
25. MacKenzie KL, Franco S, May C, Sadelain M, Moore MA: Mass cultured human fibroblasts overexpressing hTERT encounter, a growth crisis following an extended period of proliferation. Exp Cell Res 259: 336-350, 2000
26. Ren JG, Xia HL, Tian YM, Just T, Cai GP, Dai YR: Expression of telomerase inhibits hydroxyl radical-induced apoptosis in normal telomerase negative human lung fibroblasts. FEBS Lett 488: 133-138, 2001
27. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 345: 458-460, 1990
28. Hastie N, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC: Telomere reduction in human colorectal carcinoma and with ageing. Nature 346: 866-868, 1990
29. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB, Morin GB: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genet 17: 498-502, 1997
30. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997
31. Jiang X, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tisty TD, Chin C: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genet 21: 111-114, 1999
32. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White A, Wright WE, Shay JW: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nature Genet 21: 115-118, 1999
33. Vaziri H, Squire JA, Pandita TK, Bradley G, Kuba RM, Zhang H, Gulyas S, Hill RP, Nolan GP, Benchimol S: Analysis of genomic integrity and p53-dependent G, checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol Cell Biol 19: 2373-2379, 1999
34. Savre-Train I, Gollahon LS, Holt SE: Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines. Proc Soc Exp Biol Med 223: 379-388, 2000
35. Holt SE, Norton JC, Wright WE, Shay JW: Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Meth Cell Sci 18: 237-248, 1996
36. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medranos EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367, 1995
37. Beattie TL, Zhou W, Robinson M, Harrington L: Reconstitution of human telomerase activity in vitro. Curr Biol 8: 117-180, 1998
38. Dubrovskaya VA, Wetterhahn KE: Effects of CR(VI) on the expression of the oxidative stress genes in human lung cells. Carcinogenesis 19: 1401-1407, 1998
39. Bidulescu A, Wise SS, May A, Tang ER, Bryant BH, Schumm KR, Wise JP Sr: Hexavalent chromium toxicity in human lung cells, Chinese hamster ovary cells and A549 cells: Current cell culture models are inadequate. Toxicol Sci 66: 32, 2002
40. Ouellette MM, Liao M, Herbert B-S, Johnson M, Holt SE, Liss HS, Shay JW, Wright WE: Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase. J Biol Chem 275: 10072-10076, 2000
41. Pritchard DE, Ceryak S, Ha L, Fornsaglio JL, Hartman SK, O'Brien TJ, Patierno SR: Mechanism of apoptosis and determination of cellular fate in chromium(VI)-exposed populations of telomerase immortalized fibroblasts. Cell Growth Diff 12: 347-363, 2001
42. Yunis JJ: The chromosomal basis for human neoplasia. Science 221: 227-236, 1983
43. Cavanee WK, Dryja TP, Phillips RA, Benedict WE Godbout R, Gallie BL, Murphee AL, Strong LC, White RL: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784, 1983
44. Adams J, Gerondakis S, Webb E, Corcoran LM, Cory S: Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in marine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci USA 80: 1982-1986, 1983
45. Davis RL, Konopka JB, Witte ON: Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Mol Cell Biol 5 204-213, 1985